Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;29(3):257-69.
doi: 10.3803/EnM.2014.29.3.257. Epub 2014 Sep 25.

Cost-of-Illness Trends Associated with Thyroid Disease in Korea

Kyung-Rae Hyun  1 , Sungwook Kang  2 , Sunmi Lee  1
Affiliations

Cost-of-Illness Trends Associated with Thyroid Disease in Korea

Kyung-Rae Hyun et al. Endocrinol Metab (Seoul). 2014 Sep.

Abstract

Background: The purpose of this study is to analyze the scale of and trends associated with the cost-of-illness of thyroid disease in Korea at 2-year intervals during the last 10 years for which data are available.

Methods: Cost-of-illness was estimated in terms of direct and indirect costs. Direct costs include direct medical costs due to hospitalization, outpatient and pharmacy sectors, transportation, and care-giver costs. Indirect costs include future income loss due to premature death and loss of productivity as a result of absence from work.

Results: The cost-of-illness of thyroid disease in Korea was estimated at 224.2 billion won in 2002, 303.4 billion won in 2004, 400.3 billion won in 2006, 570.4 billion won in 2008, and 762.2 billion won in 2010. For example, the cost-of-illness of thyroid disease in 2010 was 3.4 times greater compared to 2002. The direct cost of the total cost-of-illness was 69.7%, which accounted for the highest proportion of costs. Cost-of-illness for individuals between the ages of 30 and 50 accounted for the greatest share of costs.

Conclusion: The cost-of-illness of thyroid disease was relatively large in economically active age groups, and demonstrated a very rapid growth rate compared to other major diseases in Korea. Therefore, we suggest nationwide recognition of the importance of prevention and management of thyroid disease and prioritization of the management of thyroid disease among current and future health promotion policies in Korea.

Keywords: Cost of illness; Direct cost; Indirect cost; Thyroid Diseases.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

    1. Kim ES. Targeted therapies in thyroid cancer. Endocrinol Metab. 2010;25:94–97.
    1. The Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2010 [Internet] Koyang: National Cancer Center; 2012. [cited 2013 Mar 29]. Available from: http://www.korea.kr/archive/expDocView.do?docId=33637.
    1. Choi JY, Youn YK. Vision of thyroid surgery: past, present and future. J Korean Thyroid Assoc. 2012;5:1–5.
    1. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) J Clin Endocrinol Metab. 2002;87:489–499. - PubMed
    1. Choi HS, Park YJ, Kim HK, Choi SH, Lim S, Park DJ, Jang HC, Cho NH, Cho BY. Prevalence of subclinical hypothyroidism in two population based-cohort: Ansung and KLoSHA cohort in Korea. J Korean Thyroid Assoc. 2010;3:32–40.

LinkOut - more resources